OHSU gobbles up the lion’s share of National Institutes of Health grant funding flowing into Oregon, but that still leaves plenty to go around.
Charlie Leight
OHSU gobbles up the lion’s share of National Institutes of Health grant funding flowing into Oregon, but that still leaves plenty to go around.
The Business Journal’s list of Top NIH, posted today, shows that NIH funding fell nearly 6% in the year ended in September to about $400 million, but that’s way up from six years ago.
Every grant has a story behind it, a big idea, a potential cure or game-changing innovation.
Here are a few of the top FY2021 non-OHSU-based biotech recipients, though some spun out from the university.
- PDX Pharmaceuticals, an OHSU spinout that is advancing two therapeutic candidates for advanced cancers
- Aronora Inc., which is developing cardiovascular drugs
- Hemex Health, which is creating a point-of-care product with the potential "to greatly reduce malaria transmission and could substantially contribute towards reduction in human suffering," according to an abstract of the grant application
- Najit Technologies, which plans to use the grant to expand vaccine coverage to a broader range of patients and advance a vaccine against yellow fever
- Virogenomics Biodevelopment Inc., a therapeutic and diagnostic development company focused on multiple sclerosis
- Elex Biotech, a developer of novel drugs for heart disease with a focus on CPVT, a cause of sudden cardiac death in apparently healthy young people
- Rewire Neuroscience, which is focused on the future of biomedical research and biomarker detection
- Pacific Diabetes Technologies, which is developing an integrated solution for glucose sensing and insulin delivery into a single device
- Tricol Biomedical, which is developing wound care solutions and dental dressings based on fiber extracted from shrimp cells; the grant application says the goal is to developed an advanced hemostatic urinary catheter device assembly
- Madorra Inc., which is developing a non-pharmaceutical solution for vaginal dryness for breast cancer survivors and postmenopausal women
